Skip to main content
Log in

Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Thirty-one patients with classical or definite rheumatoid arthritis (RA), on treatment with azathioprine and sodium aurothiomalate in combination were studied. Absolute lymphocyte counts and IgA levels were reduced but this did not reach statistical significance. Lymphocyte transformation with phytohaemagglutinin (PHA) showed no significant difference from a control group. However, antibody dependent cell-mediated cytotoxicity was significantly impaired compared to rheumatoid controls (p<0.001). There was no relation to the degree of impairment of ADCC and the current dose of azathioprine nor to the total dose or duration of therapy. Inhibiting material to cell-mediated cytotoxicity was present in the sera of 23 patients but its presence showed no relation to the degree of cytotoxicity exhibited by cells in the same patient. Our studies of cellular cytotoxicity have revealed alterations in cellular function possibly attributable to azathioprine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. De Silva M. and Hazleman B. Long term azathioprine in rheumatoid arthritis. A double-blind study. Ann. Rheum. Dis. 1981, 40, 560–563.

    PubMed  Google Scholar 

  2. Haegert D.G., Hallberg T.D. and Coombs R.R.A. B and T lymphocyte subpopulations in human peripheral blood. Int. Arch. Allergy Appl. Immunol 1974, 46, 525–538.

    PubMed  Google Scholar 

  3. Hallberg T., Guru B.W. and Coombs R.R.A. Opsonic Adherence of sensitised red cell to human lymphocytes as easured by rosette formation. Int. Arch. Allergy Appl. Immunol 1973, 44, 500–513.

    PubMed  Google Scholar 

  4. Pellegrino M.A. Ferrone S., Dierich H.P. and Reisfeld R.A. Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulphydryl compound 2 — aminoethylisothiouronium bromide. Clin. Immunol. Immunopathol 1975, 3, 324–333.

    PubMed  Google Scholar 

  5. Franks D., Kelly N.M. and Sanderson C.J. Inhibition of xenogeneic cell-mediated cytotoxicity in the rat by antiglobulin sera. Int. Arch. Allergy Appl. Immonol. 1975, 48, 621–631.

    Google Scholar 

  6. Sanderson C.J. and Taylor G.A. The kinetics of51Cr release from target cells in cell mediated cytotoxicity and the relationship to the kinetics of killing. Cell Tissue Kinet. 1975, 8, 23–32.

    PubMed  Google Scholar 

  7. Denman E.J., Denman A.M., Greenwood B.M., Gall D. and Heath R.B. Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann. Rheum. Dis. 1970, 29, 220–2316.

    PubMed  Google Scholar 

  8. Micheli A. and Bron J. Studies on Blood T and B lymphocytes in rheumatoid arthritis. Ann. Rheum. Dis. 1974, 33, 435–436.

    PubMed  Google Scholar 

  9. Eremin O. Personal communication.

  10. Campbell A.C., Skinner J.M., Maclennan C.M. Hersey P., Waller C.A., Wood J., Jewell D.P. and Truelove S.C. Immunosuppression in the treatment of inflammatory bowel disease. II the effects of azathioprine on lymphoid cell populations in a double-blind trial in ulcerative colitis. Clin. Exp. Immunol 1976, 24, 249–258.

    PubMed  Google Scholar 

  11. Rosenberg J.N. and Currey H.L.F. Antibody dependent and PHA induced cellular cytotoxicity in rheumatoid arthritis. Ann. Rheum. Dis. 1979, 38, 347–350.

    PubMed  Google Scholar 

  12. Cooke L.A., Hay F.C. and Perumal R. Ann. Rheum. Dis. 1979, 38, 252–256.

    PubMed  Google Scholar 

  13. Wisloff F., Froland S.S. and Natvig J.B. Deficient lymphoid cell mediated, PHA-induced cytotoxicity in rheumatoid arthritis patients. Scand. J. Immunol. 1975, 4, 303–307.

    PubMed  Google Scholar 

  14. Froland S.S., Natvig J.B. and Wisloff F. Lymphocyte sub-populations in rheumatoid arthritis. Rheumatology 1975, 6, 231–241.

    PubMed  Google Scholar 

  15. Feldman J.L., Becker M.I., Moutsopoulos H., Fye K., Blackman M., Epstein W.V. and Talal N. Antibody-dependent cell mediated cytotoxicity in selected autoimmune diseases. J. Clin. Invest. 1976, 58, 173–179.

    PubMed  Google Scholar 

  16. Panayi G.S., and Corrigall V. Functional assay of cytotoxic lymphocytes involved in antibody-mediated cytotoxicity in normal and rheumatoid subjects. Ann. Rheum. Dis. 1977, 36, 257–260.

    PubMed  Google Scholar 

  17. Sany J., Clot J., Frietas M., Charmasson E., and Serre H. Antibody-dependent cell cytotoxicity (ADCC) of rheumatoid arthritis blood lymphocytes. Rev. Rheum. Mal. Osteoartic 1976, 43, 333–338.

    Google Scholar 

  18. Isturiz M.A., de Bracco M.M., de E., Pizzi A.M. and Manni J.A. Antibody-dependent cell mediated cytotoxicity in rheumatoid arthritis. Arthritis Rheum. 1976, 19, 725–730.

    PubMed  Google Scholar 

  19. McGill P.E. and Twinn I. Antibody-mediated cytotoxicity in rheumatoid arthritis. Ann. Rheum. Dis. 1977, 36, 268–270.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, P., Hazleman, B.L., Park, J.R. et al. Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination. Clin Rheumatol 1, 168–175 (1982). https://doi.org/10.1007/BF02042770

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02042770

Key words

Navigation